| Market Cap | 96.40K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -669.12k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 17.00% |
| Sales | 2.23k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -32.00% |
| Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -71.00% | |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 3.21B | 52W Low Chg | 100.00% |
| Insider Own | - | ROA | -1,284.20% | Shares Float | - | Beta | 201.96 |
| Inst Own | - | ROE | -2,515.50% | Shares Shorted/Prior | -/- | Price | 0.00040 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 1,862,940 | Target Price | - |
| Oper. Margin | -29,261.08% | Earnings Date | - | Volume | 23,333 | Change | 0.00% |
CTR Investments & Consulting, Inc. provides information technology services and products used by customers in the financial, private, government, and health care sectors. It specializes in identity information and data assurance; visitor management; and security technologies, including hardware and software solutions for electronic visitor management. The company's products include BioKey ID identity card systems; DataSafe products/services set for capturing and securing electronic documents and information; and a line of biometric facial recognition solutions. CTR Investments & Consulting was incorporated in 1999 and is based in Pasadena, Maryland.
